INTRODUCTION
Lung transplantation has become the ultimate therapeutic option for some patients with advanced lung disease (1) . Transplantation outcome has improved with advances in operative techniques, but optimal management of infection and rejection remains a problem, partly because these complications may be undetectable at early phases by routine clinical evaluation (2) . Long-term survival for lung recipients is dependent on the number and severity of opportunistic infections and chronic rejection episodes (3, 4) . To improve long term survival, early intervention for earliest possible detection of the infection or the rejection event is essential. The potential benefits of early detection of infection or rejection in lung allograft have recently been cited in several studies (5) (6) (7) (8) (9) .
Due to the lung transplant recipients' immune system condition, they are highly prone to acquire opportunistic infections. Considering the high prevalence of contagious diseases in the hospital environment, each extra visit for close follow up can increase the risk of infection in these highly susceptible patients (10) (11) (12) . In addition, most patients have several socio-economic problems preventing them from presenting to the transplant center for postoperative follow up. Home Spirometry is a useful
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Tanaffos 2013; 12 (1) : [64] [65] [66] [67] [68] [69] instrument that can measure lung function and help to monitor the progress of lung transplantation and aid in early detection of allograft dysfunction (13) . Home spirometers are widely used to provide easy access to more detailed information about lung function.
Despite the fact that some researchers around the world have worked hard on this topic (14, 15) , due to the cultural nature of these studies, their studies may not fully eliminate the need for more information in countries like Iran which is taking the first steps on this road.
The aim of this pilot study was to evaluate the role of home spirometry for early detection of complications in lung transplant recipients with the ultimate goal of improving the outcome of lung transplantation. supervision. During the study period and after that we asked patients about their satisfaction level about the use of home spirometry, the problems they encountered for sending the results, whether or not they had enough time to use it and if they were willing to continue using it after the study period. All data, related to episodes of complications in lung transplant recipients in both case and control groups were collected and we compared the efficacy of using home spirometry for early detection of respiratory complications
MATERIALS AND METHODS
This
RESULTS
Initially, the portable spirometry set was evaluated by comparing the results of this device with a standard spirometry device for 5 working days. No difference was detected between the two devices. Patients' performance was then evaluated to make sure that the test was performed properly. In this phase of the study, both patients were asked to perform a spirometry test once with the standard device and again with the portable one.
Meanwhile, the patients' performance was assessed by an expert. Both patients succeeded in performing the tests and no difference was seen between the results of the two devices.
In the case group, our first patient was a 23 year-old man who had been suffering from cystic fibrosis and underwent lung transplantation in March 2011. During his follow up, he faced two episodes of complications but had no hospitalization. We monitored him for 160 days during which his PFT and vital signs were normal. His adherence to the test was 61% and he was very satisfied with this new method. The reason why he did not show a high adherence to performing the test was because of not having internet access throughout the day due to local network problems.
Therefore, he usually sent his test results every other day (a total of 97 times).
Our second patient was a 24 year-old man who underwent lung transplantation in April 2011 due to cystic fibrosis. We received 111 test results from him during a period of 139 days and his adherence was 80%. He also declared good satisfaction in using this method. During his follow up, he reported two episodes of post nasal discharge but with no spirometric evidence of lung problem, which was diagnosed and treated as sinusitis. He faced one episode of H1N1 flu, which according to our home spirometry he had a dramatic fall in FEV1, 2 days before his clinical manifestations. Therefore, he was hospitalized, diagnosed immediately and treated accordingly. He was discharged after one month with no complications.
Both patients in the case group declared good satisfaction, especially during the first two months and they admitted that being in contact with a medical staff and being evaluated on a daily basis was very reassuring.
But after four months their compliance declined and they complained that sending 2 PFT in one day was time consuming. To cope with that we asked them to send their PFTs daily instead of two times per day but warned them not to hesitate when any sign of complications occurred.
Overall, patients' compliance and adherence to the test performing decreased after four months of monitoring.
In the control group, we followed two patients for six months after their lung transplantation. The first patient was a 28 year-old woman who had been suffering from bronchiectasis. She underwent lung transplantation and during six months of her follow up, she faced five episodes of complications and was hospitalized three times. The first episode was vomiting and gastric pain, which was diagnosed to be a drug reaction and by adjusting her medications, she was discharged in good condition. In her second episode, she presented with fever, consecutive vomiting and infiltration in her chest radiography. She was hospitalized with suspicion of transplant rejection but was discharged after 2 weeks in good condition. Again, she suffered from common cold symptoms but the follow up tests were normal, therefore she was treated as an outpatient. Through the last episode, and the hardest one, FEV1 for detection of complications of heart-lung and bilateral-lung transplant recipients has been stated to range from 60 to 75% in the previous studies (12) . Furthermore, as reported by Martinez and colleagues, declines of >/= 11% in FVC or 12% in FEV1 were related to allograft dysfunction due to infection or rejection in heart-lung and bilateral-lung transplant patients (17) . During the recent years, home spirometry has been considered as a practical tool in this regard (5, 10, (13) (14) (15) (16) (17) (18) . Since the burden of using home spirometry in limited resource setting must have a logical justification (19) , the present study was designed to evaluate the affordability and feasibility of home spirometry and assess its power in early detection of complications in lung transplant patients. Our study showed that home spirometry is a reliable device for measuring pulmonary function and Iranian lung transplant recipients have good adherence to this method.
Our pilot study also showed that home spirometry in (12). Lindgren and coworkers also reported a tiny (120 ml) difference among spirometry measurements at home and clinic (14) . Meanwhile, similar to the findings of the latter study (14) and another research conducted by Finkelstein and coworkers (20) , our participants also proved that they have the ability of learning and performing spirometry properly by themselves at home.
These findings suggest that we can trust home spirometry as a reliable tool for assessing pulmonary function in lung transplant recipients. The next step was to evaluate adherence of patients to the home spirometry in the first 6 months after discharge from hospital. One of our cases used home spirometry on a regular daily basis and sent the results to the research group as predicted and an adherence of 80% was calculated for him. In the second case, which was not as punctual as the first one, we also observed % 61 adherences to home spirometry. Although if he had not have problem with internet connection, he might have shown a higher rate of adherence. These findings are comparable with other studies. In Belgium, Morlion and coworkers achieved average adherence of 55% for two measurement sessions a day and 84% for one measurement session daily (12) . Finkelstein SM and colleagues reported 82% adherence for sending spirometry data once a week (21) . Another noticeable point in this regard which was completely similar to the results of above-mentioned studies was the decreasing trend of patient adherence with the passing of time. While Sabati and colleagues indicated poor health status, laziness and time conflict as barriers to adherence in their research (11) , being time consuming and problem in internet access were the major setbacks for patient adherence in our study. One bright aspect of using home spirometry and daily check of its result is that the care givers can have a close observation of the patients and if the lung transplant recipients do not send the routine results they can contact them and follow any possible unexpected events. This kind of close contact is also stated to be a beneficial factor in promoting adherence by Chlan and coworkers (22) .
As the main goal of this study, we determined the In conclusion, our study showed that home spirometry monitoring is feasible and reliable for lung transplant recipients. Pulmonary function parameters collected by this portable spirometry device and without professional supervision were valid and comparable to those collected by the standard device at the spirometry laboratory of the hospital. In addition, the patients were satisfied with the method and were willing to cooperate in the future. But in order to include this method in lung transplantation follow up protocol of our country, future studies with a larger number of patients and using better communication methods are essential.
